Bulk RNA sequencing of biopsy samples showed that TME was remodeled from immune-excluded/desert to immune-inflamed tumor in responders, including enriched pro-tumor immunity signatures and anti-tumor cytokines, increased density of effector T-cell in tumor-infiltrating lymphocytes (TILs), and elevated PD-L1 expression. This evidence concerns the gene CD274 and neoplasm.